1. Home
  2. HALO vs BWXT Comparison

HALO vs BWXT Comparison

Compare HALO & BWXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • BWXT
  • Stock Information
  • Founded
  • HALO 1998
  • BWXT 1867
  • Country
  • HALO United States
  • BWXT United States
  • Employees
  • HALO N/A
  • BWXT N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • BWXT
  • Sector
  • HALO Health Care
  • BWXT
  • Exchange
  • HALO Nasdaq
  • BWXT Nasdaq
  • Market Cap
  • HALO 7.4B
  • BWXT 8.6B
  • IPO Year
  • HALO N/A
  • BWXT N/A
  • Fundamental
  • Price
  • HALO $56.07
  • BWXT $125.61
  • Analyst Decision
  • HALO Buy
  • BWXT Strong Buy
  • Analyst Count
  • HALO 9
  • BWXT 11
  • Target Price
  • HALO $63.56
  • BWXT $131.36
  • AVG Volume (30 Days)
  • HALO 3.5M
  • BWXT 1.2M
  • Earning Date
  • HALO 05-06-2025
  • BWXT 05-05-2025
  • Dividend Yield
  • HALO N/A
  • BWXT 0.80%
  • EPS Growth
  • HALO 55.40
  • BWXT 13.77
  • EPS
  • HALO 3.76
  • BWXT 3.14
  • Revenue
  • HALO $1,084,306,000.00
  • BWXT $2,781,946,000.00
  • Revenue This Year
  • HALO $25.77
  • BWXT $15.14
  • Revenue Next Year
  • HALO $18.01
  • BWXT $9.77
  • P/E Ratio
  • HALO $14.92
  • BWXT $40.00
  • Revenue Growth
  • HALO 25.64
  • BWXT 9.88
  • 52 Week Low
  • HALO $42.01
  • BWXT $84.21
  • 52 Week High
  • HALO $70.51
  • BWXT $136.31
  • Technical
  • Relative Strength Index (RSI)
  • HALO 48.34
  • BWXT 74.95
  • Support Level
  • HALO $54.00
  • BWXT $106.22
  • Resistance Level
  • HALO $55.25
  • BWXT $127.64
  • Average True Range (ATR)
  • HALO 2.53
  • BWXT 3.45
  • MACD
  • HALO 0.14
  • BWXT 1.73
  • Stochastic Oscillator
  • HALO 42.01
  • BWXT 91.01

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About BWXT BWX Technologies Inc.

BWX Technologies Inc is a specialty manufacturer & service provider of nuclear components. It operates in two segments. The government Operations segment consists of legacy Nuclear Operations Group & Nuclear Services Group segments with certain research & development activities in the areas of advanced reactors & advanced manufacturing. The commercial Operations segment consists of the legacy Nuclear Power Group segment with certain research and development & commercialization activities in the areas of medical & industrial radioisotopes & radiopharmaceuticals. The majority is from the Government Operations segment. Geographically, it operates in the United States, Canada & United Kingdom, out of which the majority is from the United States.

Share on Social Networks: